Takeda`s blood cancer drug flunks phase 3 in setback to R&D pla
03 Sep 2021 //
FIERCEBIOTECH
Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
01 Sep 2021 //
BUSINESSWIRE
Takeda Announces U.S. FDA Breakthrough Therapy Granted for Pevonedistat
30 Jul 2020 //
PRESS RELEASE